Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

Long-term outcomes of semi-implantable functional electrical stimulation for central drop foot.

Buentjen L, Kupsch A, Galazky I, Frantsev R, Heinze HJ, Voges J, Hausmann J, Sweeney-Reed CM.

J Neuroeng Rehabil. 2019 Jun 11;16(1):72. doi: 10.1186/s12984-019-0542-8.

2.

Electric stimulation of the medial forebrain bundle influences sensorimotor gaiting in humans.

Panther P, Kuehne M, Voges J, Nullmeier S, Kaufmann J, Hausmann J, Bittner D, Galazky I, Heinze HJ, Kupsch A, Zaehle T.

BMC Neurosci. 2019 Apr 29;20(1):20. doi: 10.1186/s12868-019-0503-y.

3.

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.

Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig TD, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, Kühn A, Kupsch A, Schneider GH, Seigneuret E, Fraix V, Kistner A, Chaynes PP, Ory-Magne F, Brefel-Courbon C, Vesper J, Wojtecki L, Derrey S, Maltête D, Damier P, Derkinderen P, Sixel-Döring F, Trenkwalder C, Gharabaghi A, Wächter T, Weiss D, Pinsker MO, Regis JM, Witjas T, Thobois S, Mertens P, Knudsen K, Schade-Brittinger C, Houeto JL, Agid Y, Vidailhet M, Timmermann L, Deuschl G; EARLYSTIM study group.

Neurology. 2019 Mar 5;92(10):e1109-e1120. doi: 10.1212/WNL.0000000000007037. Epub 2019 Feb 8. Erratum in: Neurology. 2019 Jun 11;92(24):1166.

4.

Longterm outcome of cognition, affective state, and quality of life following subthalamic deep brain stimulation in Parkinson's disease.

Gruber D, Calmbach L, Kühn AA, Krause P, Kopp UA, Schneider GH, Kupsch A.

J Neural Transm (Vienna). 2019 Mar;126(3):309-318. doi: 10.1007/s00702-019-01972-7. Epub 2019 Jan 25.

PMID:
30684055
5.

Neurostimulation in tardive dystonia/dyskinesia: A delayed start, sham stimulation-controlled randomized trial.

Gruber D, Südmeyer M, Deuschl G, Falk D, Krauss JK, Mueller J, Müller JU, Poewe W, Schneider GH, Schrader C, Vesper J, Volkmann J, Winter C, Kupsch A, Schnitzler A; DBS study group for dystonia.

Brain Stimul. 2018 Nov - Dec;11(6):1368-1377. doi: 10.1016/j.brs.2018.08.006. Epub 2018 Sep 11.

PMID:
30249417
6.

[Effectiveness and safety of safinamide as add-on to levodopa in patients with parkinson's disease: non-interventional study].

Jost WH, Kupsch A, Mengs J, Delf M, Bosse D.

Fortschr Neurol Psychiatr. 2018 Oct;86(10):624-634. doi: 10.1055/a-0665-4667. Epub 2018 Aug 24. German.

PMID:
30142650
7.

Pallidal Stimulation Modulates Pedunculopontine Nuclei in Parkinson's Disease.

Galazky I, Kluge C, Schmitt FC, Kopitzki K, Zaehle T, Voges J, Büntjen L, Kupsch A, Hinrichs H.

Brain Sci. 2018 Jun 25;8(7). pii: E117. doi: 10.3390/brainsci8070117.

8.

Deep brain stimulation of the pedunculopontine nucleus for treatment of gait and balance disorder in progressive supranuclear palsy: Effects of frequency modulations and clinical outcome.

Galazky I, Kaufmann J, Lorenzl S, Ebersbach G, Gandor F, Zaehle T, Specht S, Stallforth S, Sobieray U, Wirkus E, Casjens F, Heinze HJ, Kupsch A, Voges J.

Parkinsonism Relat Disord. 2018 May;50:81-86. doi: 10.1016/j.parkreldis.2018.02.027. Epub 2018 Feb 19.

PMID:
29503154
9.

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group.

Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8.

PMID:
29452685
10.

Bilateral thalamic deep brain stimulation for essential tremor in elderly patients.

Klein J, Büntjen L, Jacobi G, Galazky I, Panther P, Zaehle T, Kaufmann J, Heinze HJ, Voges J, Kupsch A.

J Neural Transm (Vienna). 2017 Sep;124(9):1093-1096. doi: 10.1007/s00702-017-1741-8. Epub 2017 Jun 7.

PMID:
28593500
11.

Connectivity Predicts deep brain stimulation outcome in Parkinson disease.

Horn A, Reich M, Vorwerk J, Li N, Wenzel G, Fang Q, Schmitz-Hübsch T, Nickl R, Kupsch A, Volkmann J, Kühn AA, Fox MD.

Ann Neurol. 2017 Jul;82(1):67-78. doi: 10.1002/ana.24974.

12.

Interhemispheric connectivity in amyotrophic lateral sclerosis: A near-infrared spectroscopy and diffusion tensor imaging study.

Kopitzki K, Oldag A, Sweeney-Reed CM, Machts J, Veit M, Kaufmann J, Hinrichs H, Heinze HJ, Kollewe K, Petri S, Mohammadi B, Dengler R, Kupsch AR, Vielhaber S.

Neuroimage Clin. 2016 Sep 29;12:666-672. eCollection 2016.

13.

Long-term results of deep brain stimulation in a cohort of eight children with isolated dystonia.

Krause P, Lauritsch K, Lipp A, Horn A, Weschke B, Kupsch A, Kiening KL, Schneider GH, Kühn AA.

J Neurol. 2016 Nov;263(11):2319-2326. Epub 2016 Aug 27.

PMID:
27567612
14.

Near-infrared spectroscopy and transcranial sonography to evaluate cerebral autoregulation in middle cerebral artery steno-occlusive disease.

Oldag A, Neumann J, Goertler M, Hinrichs H, Heinze HJ, Kupsch A, Sweeney-Reed CM, Kopitzki K.

J Neurol. 2016 Nov;263(11):2296-2301. Epub 2016 Aug 20.

PMID:
27544503
15.

Disease-specific longevity of impulse generators in deep brain stimulation and review of the literature.

van Riesen C, Tsironis G, Gruber D, Klostermann F, Krause P, Schneider GH, Kupsch A.

J Neural Transm (Vienna). 2016 Jun;123(6):621-30. doi: 10.1007/s00702-016-1562-1. Epub 2016 May 19. Review.

PMID:
27198700
16.

Long-term effect on dystonia after pallidal deep brain stimulation (DBS) in three members of a family with a THAP1 mutation.

Krause P, Brüggemann N, Völzmann S, Horn A, Kupsch A, Schneider GH, Lohmann K, Kühn A.

J Neurol. 2015 Dec;262(12):2739-44. doi: 10.1007/s00415-015-7908-z. Epub 2015 Oct 20.

PMID:
26486352
17.

Missing wedge computed tomography by iterative algorithm DIRECTT.

Kupsch A, Lange A, Hentschel MP, Lück S, Schmidt V, Grothausmann R, Hilger A, Manke I.

J Microsc. 2015 Jan;261(1):36-45. doi: 10.1111/jmi.12313. Epub 2015 Sep 14.

18.

Safe Administration of Botulinum Toxin Type A Injections During Pregnancy: A Report of Two Cases.

Krug H, Krause P, Kupsch A, Kühn AA.

Mov Disord Clin Pract. 2015 May 6;2(2):187-189. doi: 10.1002/mdc3.12135. eCollection 2015 Jun.

19.

A dedicated compression device for high resolution X-ray tomography of compressed gas diffusion layers.

Tötzke C, Manke I, Gaiselmann G, Bohner J, Müller BR, Kupsch A, Hentschel MP, Schmidt V, Banhart J, Lehnert W.

Rev Sci Instrum. 2015 Apr;86(4):043702. doi: 10.1063/1.4918291.

PMID:
25933863
20.

Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia.

Brüggemann N, Kühn A, Schneider SA, Kamm C, Wolters A, Krause P, Moro E, Steigerwald F, Wittstock M, Tronnier V, Lozano AM, Hamani C, Poon YY, Zittel S, Wächter T, Deuschl G, Krüger R, Kupsch A, Münchau A, Lohmann K, Volkmann J, Klein C.

Neurology. 2015 Mar 3;84(9):895-903. doi: 10.1212/WNL.0000000000001312. Epub 2015 Feb 4.

21.

Failure of Pallidal Deep Brain Stimulation in a Case of Rapid-Onset Dystonia Parkinsonism (DYT12).

Brücke C, Horn A, Huppke P, Kupsch A, Schneider GH, Kühn AA.

Mov Disord Clin Pract. 2014 Dec 30;2(1):76-78. doi: 10.1002/mdc3.12124. eCollection 2015 Mar. No abstract available.

22.
23.

Postoperative MRI localisation of electrodes and clinical efficacy of pallidal deep brain stimulation in cervical dystonia.

Schönecker T, Gruber D, Kivi A, Müller B, Lobsien E, Schneider GH, Kühn AA, Hoffmann KT, Kupsch AR.

J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):833-9. doi: 10.1136/jnnp-2014-308159. Epub 2014 Sep 24.

PMID:
25253870
24.

Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial.

Volkmann J, Mueller J, Deuschl G, Kühn AA, Krauss JK, Poewe W, Timmermann L, Falk D, Kupsch A, Kivi A, Schneider GH, Schnitzler A, Südmeyer M, Voges J, Wolters A, Wittstock M, Müller JU, Hering S, Eisner W, Vesper J, Prokop T, Pinsker M, Schrader C, Kloss M, Kiening K, Boetzel K, Mehrkens J, Skogseid IM, Ramm-Pettersen J, Kemmler G, Bhatia KP, Vitek JL, Benecke R; DBS study group for dystonia.

Lancet Neurol. 2014 Sep;13(9):875-84. doi: 10.1016/S1474-4422(14)70143-7. Epub 2014 Aug 7.

PMID:
25127231
25.

Influence of the nonergot dopamine agonist piribedil on vigilance in patients With Parkinson Disease and excessive daytime sleepiness (PiViCog-PD): an 11-week randomized comparison trial against pramipexole and ropinirole.

Eggert K, Öhlwein C, Kassubek J, Wolz M, Kupsch A, Ceballos-Baumann A, Ehret R, Polzer U, Klostermann F, Schwarz J, Fuchs G, Jost W, Albert A, Haag A, Hermsen A, Lohmüller K, Kuhn K, Wangemann M, Oertel WH; In Cooperation With the German Competence Network on Parkinson’s Disease.

Clin Neuropharmacol. 2014 Jul-Aug;37(4):116-22. doi: 10.1097/WNF.0000000000000041.

PMID:
24992083
26.

Safety analysis of 10 clinical trials and for 13 years after first approval of ioflupane 123I injection (DaTscan).

Grosset DG, Tatsch K, Oertel WH, Tolosa E, Bajaj N, Kupsch A, O'Brien JT, Seibyl J, Walker Z, Sherwin P, Chen C, Grachev ID.

J Nucl Med. 2014 Aug;55(8):1281-7. doi: 10.2967/jnumed.114.138032. Epub 2014 Jun 19.

27.

Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imaging.

Seibyl JP, Kupsch A, Booij J, Grosset DG, Costa DC, Hauser RA, Darcourt J, Bajaj N, Walker Z, Marek K, McKeith I, O'Brien JT, Tatsch K, Tolosa E, Dierckx RA, Grachev ID.

J Nucl Med. 2014 Aug;55(8):1288-96. doi: 10.2967/jnumed.114.140228. Epub 2014 Jun 12.

28.

Oscillatory subthalamic nucleus activity is modulated by dopamine during emotional processing in Parkinson's disease.

Huebl J, Spitzer B, Brücke C, Schönecker T, Kupsch A, Alesch F, Schneider GH, Kühn AA.

Cortex. 2014 Nov;60:69-81. doi: 10.1016/j.cortex.2014.02.019. Epub 2014 Mar 6.

PMID:
24713195
29.

Quadruple deep brain stimulation in Huntington's disease, targeting pallidum and subthalamic nucleus: case report and review of the literature.

Gruber D, Kuhn AA, Schoenecker T, Kopp UA, Kivi A, Huebl J, Lobsien E, Mueller B, Schneider GH, Kupsch A.

J Neural Transm (Vienna). 2014 Oct;121(10):1303-12. doi: 10.1007/s00702-014-1201-7. Epub 2014 Apr 4. Review.

PMID:
24699718
30.

6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson's disease: respirometric, histological, and behavioral analyses.

Kupsch A, Schmidt W, Gizatullina Z, Debska-Vielhaber G, Voges J, Striggow F, Panther P, Schwegler H, Heinze HJ, Vielhaber S, Gellerich FN.

J Neural Transm (Vienna). 2014 Oct;121(10):1245-57. doi: 10.1007/s00702-014-1185-3. Epub 2014 Mar 14.

PMID:
24627045
31.

The dystonia discomfort scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia.

Dressler D, Kupsch A, Seitzinger A, Paus S.

Eur J Neurol. 2014 Mar;21(3):459-62. doi: 10.1111/ene.12330. Epub 2014 Jan 16.

PMID:
24433495
32.

Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry.

Schramm A, Ndayisaba JP, Auf dem Brinke M, Hecht M, Herrmann C, Huber M, Lobsien E, Mehnert S, Reuter I, Stenner A, van der Ven C, Winterholler M, Kupsch A, Wissel J.

J Neural Transm (Vienna). 2014 May;121(5):521-30. doi: 10.1007/s00702-013-1145-3. Epub 2014 Jan 10.

PMID:
24407377
33.

Impact of physical exercise on reaction time in patients with Parkinson's disease-data from the Berlin BIG Study.

Ebersbach G, Ebersbach A, Gandor F, Wegner B, Wissel J, Kupsch A.

Arch Phys Med Rehabil. 2014 May;95(5):996-9. doi: 10.1016/j.apmr.2013.10.020. Epub 2013 Nov 11.

PMID:
24231400
34.

Guillain-Barre/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa/carbidopa treatment.

Galazky I, Schoof J, Stallforth S, Kupsch A, Heinze HJ, Kluge C.

Parkinsonism Relat Disord. 2014 Jan;20(1):125-7. doi: 10.1016/j.parkreldis.2013.08.007. Epub 2013 Aug 22. No abstract available.

PMID:
24044946
35.

Antidepressant effects after short-term and chronic stimulation of the subgenual cingulate gyrus in treatment-resistant depression.

Merkl A, Schneider GH, Schönecker T, Aust S, Kühl KP, Kupsch A, Kühn AA, Bajbouj M.

Exp Neurol. 2013 Nov;249:160-8. doi: 10.1016/j.expneurol.2013.08.017. Epub 2013 Sep 5.

PMID:
24012926
36.

Levodopa inhibits habit-learning in Parkinson’s disease.

Fuhrer H, Kupsch A, Hälbig TD, Kopp UA, Scherer P, Gruber D.

J Neural Transm (Vienna). 2014 Feb;121(2):147-51.

PMID:
23959161
37.

Diffusion tensor imaging in idiopathic Parkinson's disease and multisystem atrophy (Parkinsonian type).

Cnyrim CD, Kupsch A, Ebersbach G, Hoffmann KT.

Neurodegener Dis. 2014;13(1):1-8. doi: 10.1159/000348512. Epub 2013 May 24.

PMID:
23711586
38.

Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia.

Dressler D, Paus S, Seitzinger A, Gebhardt B, Kupsch A.

J Neurol Neurosurg Psychiatry. 2013 Sep;84(9):1014-9. doi: 10.1136/jnnp-2012-303608. Epub 2013 May 18.

39.

Neurostimulation for Parkinson's disease with early motor complications.

Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Hälbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltête D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Krüger R, Pinsker MO, Amtage F, Régis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G; EARLYSTIM Study Group.

N Engl J Med. 2013 Feb 14;368(7):610-22. doi: 10.1056/NEJMoa1205158.

40.

Involvement of human internal globus pallidus in the early modulation of cortical error-related activity.

Herrojo Ruiz M, Huebl J, Schönecker T, Kupsch A, Yarrow K, Krauss JK, Schneider GH, Kühn AA.

Cereb Cortex. 2014 Jun;24(6):1502-17. doi: 10.1093/cercor/bht002. Epub 2013 Jan 24.

PMID:
23349222
41.

Impact of subcortical white matter lesions on dopamine transporter SPECT.

Funke E, Kupsch A, Buchert R, Brenner W, Plotkin M.

J Neural Transm (Vienna). 2013 Jul;120(7):1053-60. doi: 10.1007/s00702-013-0977-1. Epub 2013 Jan 24.

PMID:
23344720
42.

Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial.

Volkmann J, Wolters A, Kupsch A, Müller J, Kühn AA, Schneider GH, Poewe W, Hering S, Eisner W, Müller JU, Deuschl G, Pinsker MO, Skogseid IM, Roeste GK, Krause M, Tronnier V, Schnitzler A, Voges J, Nikkhah G, Vesper J, Classen J, Naumann M, Benecke R; DBS study group for dystonia.

Lancet Neurol. 2012 Dec;11(12):1029-38. doi: 10.1016/S1474-4422(12)70257-0. Epub 2012 Nov 1.

PMID:
23123071
43.

Mapping brain regions in which deep brain stimulation affects schizophrenia-like behavior in two rat models of schizophrenia.

Klein J, Hadar R, Götz T, Männer A, Eberhardt C, Baldassarri J, Schmidt TT, Kupsch A, Heinz A, Morgenstern R, Schneider M, Weiner I, Winter C.

Brain Stimul. 2013 Jul;6(4):490-9. doi: 10.1016/j.brs.2012.09.004. Epub 2012 Oct 8.

PMID:
23085443
44.

Enhanced low-frequency oscillatory activity of the subthalamic nucleus in a patient with dystonia.

Neumann WJ, Huebl J, Brücke C, Ruiz MH, Kupsch A, Schneider GH, Kühn AA.

Mov Disord. 2012 Jul;27(8):1063-6. doi: 10.1002/mds.25078. Epub 2012 Jun 14.

PMID:
22700436
45.

Changes in clinical management and diagnosis following DaTscan SPECT imaging in patients with clinically uncertain parkinsonian syndromes: a 12-week follow-up study.

Kupsch A, Bajaj N, Weiland F, Tartaglione A, Klutmann S, Copp R, Sherwin P, Tate A, Grachev ID.

Neurodegener Dis. 2013;11(1):22-32. Epub 2012 May 8.

PMID:
22571977
46.

Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study.

Kupsch AR, Bajaj N, Weiland F, Tartaglione A, Klutmann S, Buitendyk M, Sherwin P, Tate A, Grachev ID.

J Neurol Neurosurg Psychiatry. 2012 Jun;83(6):620-8. doi: 10.1136/jnnp-2011-301695. Epub 2012 Apr 6.

PMID:
22492213
47.

Scaling of movement is related to pallidal γ oscillations in patients with dystonia.

Brücke C, Huebl J, Schönecker T, Neumann WJ, Yarrow K, Kupsch A, Blahak C, Lütjens G, Brown P, Krauss JK, Schneider GH, Kühn AA.

J Neurosci. 2012 Jan 18;32(3):1008-19. doi: 10.1523/JNEUROSCI.3860-11.2012.

48.

Development of an implantable microstimulation system for chronic DBS in rodents.

Paulat R, Meissner W, Morgenstern R, Kupsch A, Harnack D.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:660-2. doi: 10.1109/IEMBS.2011.6090147.

PMID:
22254395
49.

No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease.

Lobsien E, Schreiner S, Plotkin M, Kupsch A, Schreiber SJ, Doepp F.

Mov Disord. 2012 Mar;27(3):450-3. doi: 10.1002/mds.24070. Epub 2012 Jan 11.

PMID:
22237792
50.

Neurochemical characterization of the striatum and the nucleus accumbens in L-type Ca(v)1.3 channels knockout mice.

Sagala FS, Harnack D, Bobrov E, Sohr R, Gertler C, James Surmeier D, Kupsch A.

Neurochem Int. 2012 Feb;60(3):229-32. doi: 10.1016/j.neuint.2011.12.009. Epub 2011 Dec 19.

PMID:
22202668

Supplemental Content

Loading ...
Support Center